Thus, one hypothesis is that the inhibitory effect of TLT on CHK1 and AMPK (and subsequently the LKB1-AMPK-TSC-mTOR node) could lead to an equally effective response against bladder cancer. The gene discussed is STK11; the disease is urinary bladder carcinoma.